A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung

Liang,Rui; Chen,Tian‑Xing; Wang,Zhi‑Qiang; Jin,Ke‑Wei; Zhang,Lian‑Yu; Yan,Qing‑Na; Zhang,Hui‑Hua; Wang,Wan‑Pu

doi:10.3892/etm.2014.2075

A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung

Authors:
- Rui Liang
- Tian‑Xing Chen
- Zhi‑Qiang Wang
- Ke‑Wei Jin
- Lian‑Yu Zhang
- Qing‑Na Yan
- Hui‑Hua Zhang
- Wan‑Pu Wang
View Affiliations

Affiliations: Department of Pathology, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China, Department of Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China, Department of Pathology, Kunming Medical University, Kunming, Yunnan 650031, P.R. China, Department of Pathology, The Affiliated Cancer Hospital of Tianjin Medical University, Tianjin 300060, P.R. China
Published online on: November 17, 2014 https://doi.org/10.3892/etm.2014.2075
Pages: 197-202

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to analyze and summarize the clinicopathological characteristics of large‑cell lung carcinoma (LCLC) of the lung, in order to improve the definite diagnosis rate of LCLC. Clinicopathological data of 174 patients with LCLC, confirmed pathologically, were retrospectively reviewed. The 174 cases of LCLC accounted for 5.7% of the total lung cancer cases during the corresponding time period at the Affiliated Cancer Hospital of Tianjin Medical University (Tianjin, China), among which there were 131 males and 43 females with an average age of 61.4 years. The postoperative pathological diagnosis of the 174 cases showed 80 cases of classic LCLC, 64 cases of large cell neuroendocrine carcinoma (LCNEC), six cases of combined LCNEC, 19 cases of basaloid carcinoma, three cases of clear cell carcinoma and two cases of lymphoepithelioma‑like carcinoma. Of the total 174 LCLC cases, 96 patients exhibited lymph node metastasis. LCLC is a highly aggressive malignancy with a high tendency of invasion and metastasis, although the incidence rate is low. A definite diagnosis of LCLC primarily relies on the pathological diagnosis. Each subtype of LCLC has its own pathomorphological and immunohistochemical characteristics.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA-Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
2	Travis WD, Brambilla E, Muller-Hermelink HK and Harris CC: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press; Lyon: 2004
3	Hanagiri T, Oka S, Takenaka S, et al: Results of surgical resection for patients with large cell carcinoma of the lung. Int J Surg. 8:391–394. 2010. View Article : Google Scholar : PubMed/NCBI
4	Battafarano RJ, Fernandez FG, Ritter J, et al: Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg. 130:166–172. 2005. View Article : Google Scholar : PubMed/NCBI
5	Zhang J, Yu JP, Yu WW, et al: Relationship between VEGF expression and dendritic cells and regulatory T cell distribution in large cell lung cancer. Zhongguo Zhong Liu Lin Chuang. 39:1501–1504. 2012.(In Chinese).
6	Zhu R, Liu JM and Wang L: Clinical analysis of 109 cases of large cell lung cancer. Linchuang Zhongliuxue Zazhi. 17:912–914. 2012.
7	Kobold S, Völk S, Clauditz T, et al: Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells. J Thorac Oncol. 8:1032–1042. 2013. View Article : Google Scholar : PubMed/NCBI
8	Khaghanzadeh N, Mojtahedi Z, Ramezani M, Erfani N and Ghaderi A: Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells. Daru. 20:692012. View Article : Google Scholar
9	Yousefi Z, Sarvari J, Nakamura K, et al: Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry. Folia Histochem Cytobiol. 50:368–374. 2012. View Article : Google Scholar : PubMed/NCBI
10	Sabater-Marco V, García-García JA and Roig-Vila JV: Basaloid large cell lung carcinoma presenting as cutaneous metastasis at the colostomy site after abdominoperineal resection for rectal carcinoma. J Cutan Pathol. 40:758–764. 2013. View Article : Google Scholar : PubMed/NCBI
11	Sun JM, Ahn MJ, Ahn JS, et al: Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer? Lung Cancer. 77:365–370. 2012. View Article : Google Scholar : PubMed/NCBI
12	Lubin JH and Caporaso NE: Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev. 15:517–523. 2006. View Article : Google Scholar : PubMed/NCBI
13	Xia Y, Li B, Gao N, et al: Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis. Oncol Lett. 8:1670–1674. 2014.PubMed/NCBI
14	Rekhtman N, Tafe LJ, Chaft JE, et al: Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Mod Pathol. 26:511–522. 2013. View Article : Google Scholar :
15	Buendia AJ, Sánchez J, Martinez CM and Navarro JA: Immunohistochemical characterization of a pulmonary large-cell carcinoma in a dog. Vet Pathol. 45:484–488. 2008. View Article : Google Scholar : PubMed/NCBI
16	Stojsic J, Stevic R, Kontic M, et al: Large cell lung carcinoma with unusual imaging feature, immunophenotype and genetic finding. Pathol Oncol Res. 17:175–179. 2011. View Article : Google Scholar
17	Pardo J, Martinez-Peñuela AM, Sola JJ, et al: Large cell carcinoma of the lung: an endangered species? Appl Immunohistochem Mol Morphol. 17:383–392. 2009. View Article : Google Scholar : PubMed/NCBI
18	Barbareschi M, Cantaloni C, Del Vescovo V, et al: Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Pathol. 136:773–782. 2011. View Article : Google Scholar : PubMed/NCBI
19	Watanabe R, Ito I, Kenmotsu H, et al: Large cell neuroendocrine carcinoma of the lung: is it possible to diagnose from biopsy specimens? Jpn J Clin Oncol. 43:294–304. 2013. View Article : Google Scholar : PubMed/NCBI
20	Doddoli C, Barlesi F, Chetaille B, et al: Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg. 77:1168–1172. 2004. View Article : Google Scholar : PubMed/NCBI
21	Mimae T, Yamashita M, Maeda A, et al: Large cell neuroendocrine carcinoma of the lung. Kyobu Geka. 62:442–445. 2009.PubMed/NCBI
22	Gollard R, Jhatakia S, Elliott M and Kosty M: Large cell/neuroendocrine carcinoma. Lung Cancer. 69:13–18. 2010. View Article : Google Scholar : PubMed/NCBI
23	Tanaka Y, Ogawa H, Uchino K, et al: Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy. J Thorac Cardiovasc Surg. 145:839–846. 2013. View Article : Google Scholar
24	Morbini P and Inghilleri S: Large-cell lung carcinoma with basaloid architecture and neuroendocrine differentiation: a new type of combined large-cell neuroendocrine carcinoma. Int J Surg Pathol. 19:252–258. 2011. View Article : Google Scholar
25	Fournel L, Falcoz PE, Alifano M, et al: Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience. Eur J Cardiothorac Surg. 43:111–114. 2013. View Article : Google Scholar
26	Rossi G, Cavazza A, Marchioni A, et al: Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol. 23:8774–8785. 2005. View Article : Google Scholar : PubMed/NCBI
27	Li H, Wang C, Yu J, et al: Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy. 11:1076–1083. 2009. View Article : Google Scholar : PubMed/NCBI
28	Zhao Q, Zhang H, Li Y, et al: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro. J Exp Clin Cancer Res. 29:1182010. View Article : Google Scholar : PubMed/NCBI
29	Saji H, Tsuboi M, Matsubayashi J, et al: Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy. Anticancer Drugs. 21:89–93. 2010. View Article : Google Scholar
30	Shimada Y, Niho S, Ishii G, et al: Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens. Lung Cancer. 75:368–373. 2012. View Article : Google Scholar